Biogen· @biogen · X·· 2026-10-16AI 评分22
AI 导读
#News:渤健新创投(Biogen New Ventures)很荣幸参与 Estuary Biotherapeutics 的 A 轮融资,该公司致力于开发针对常染色体显性多囊肾病(ADPKD)的靶向基因疗法。了解更多:https://spr.ly/6012BHzBe4
正文
#News: Biogen New Ventures is proud to participate in the Series A financing of Estuary Biotherapeutics, a company pioneering targeted gene therapies for autosomal dominant polycystic kidney disease (ADPKD). Learn more: https://spr.ly/6012BHzBe4
来源:Biogen · x.com